- IN₹769.77m
- IN₹1.08bn
- IN₹1.60bn
- 75
- 56
- 64
- 77
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.19 | ||
| Price to Tang. Book | 2.19 | ||
| Price to Free Cashflow | 22.15 | ||
| Price to Sales | 0.5 | ||
| EV to EBITDA | 9.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 19.84% | ||
| Return on Equity | 12.69% | ||
| Operating Margin | 6.26% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 835.44 | 956.98 | 1,226.7 | 1,611.06 | 1,596.25 | n/a | n/a | 19.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +45.7 | +65.57 | +106.32 | +27.15 | -31.19 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. The Company operates through manufacture and sale of API and its intermediates segment. The Company's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for API’s, drug intermediates and fine chemicals.
Directors
- Ghanshyam Jaju NEC (68)
- Rashmi Agarwal CCO
- Mukund Kakani MDR
- Kirti Jain EDR
- Mohit Jaju EDR
- Syed Anis Hussain IND
- Vimala Madon IND
- Dilip Patel IND (67)
- Ramesh Telugu IND
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 2nd, 1987
- Public Since
- March 6th, 1995
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange- Shares in Issue
- 7,530,500
- Address
- 1st Floor, Mayfair, Sardar Patel Road, SECUNDERABAD, 500003
- Web
- http://godavaridrugs.com/
- Phone
- +91 4027842602
- Auditors
- Ayyadevara & Co.
Upcoming Events for 530317
Godavari Drugs Ltd Annual Shareholders Meeting
Q1 2025 Godavari Drugs Ltd Earnings Release
Similar to 530317
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the Godavari Drugs share price?
As of Today at 19:09 UTC, shares in Godavari Drugs are trading at IN₹102.22. This share price information is delayed by 15 minutes.
How has the Godavari Drugs share price performed this year?
Shares in Godavari Drugs last closed at IN₹102.22 and the price had moved by +31.39% over the past 365 days. In terms of relative price strength the Godavari Drugs share price has outperformed the S&P BSE 100 Index by +0.93% over the past year.
What are the analyst and broker recommendations for Godavari Drugs?
There is no consensus recommendation for this security.
What is the Godavari Drugs dividend yield?
Godavari Drugs does not currently pay a dividend.
Does Godavari Drugs pay a dividend?
Godavari Drugs does not currently pay a dividend.
When does Godavari Drugs next pay dividends?
Godavari Drugs does not currently pay a dividend.
How do I buy Godavari Drugs shares?
To buy shares in Godavari Drugs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Godavari Drugs?
As of the previous close price of IN₹102.22, shares in Godavari Drugs had a market capitalisation of IN₹769.77m.
Where are Godavari Drugs shares listed?
Here are the trading details for Godavari Drugs:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 530317
What kind of share is Godavari Drugs?
Based on an overall assessment of its quality, value and momentum Godavari Drugs is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Godavari Drugs share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Godavari Drugs share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Godavari Drugs. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -3.97%.
As of the last closing price of IN₹102.22, shares in Godavari Drugs were trading +4.49% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Godavari Drugs PE Ratio?
The Godavari Drugs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹102.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Godavari Drugs?
Godavari Drugs' management team is headed by:
- Ghanshyam Jaju - NEC
- Rashmi Agarwal - CCO
- Mukund Kakani - MDR
- Kirti Jain - EDR
- Mohit Jaju - EDR
- Syed Anis Hussain - IND
- Vimala Madon - IND
- Dilip Patel - IND
- Ramesh Telugu - IND